SG42446A1 - Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom - Google Patents

Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom

Info

Publication number
SG42446A1
SG42446A1 SG1996011135A SG1996011135A SG42446A1 SG 42446 A1 SG42446 A1 SG 42446A1 SG 1996011135 A SG1996011135 A SG 1996011135A SG 1996011135 A SG1996011135 A SG 1996011135A SG 42446 A1 SG42446 A1 SG 42446A1
Authority
SG
Singapore
Prior art keywords
preventing
disease caused
dry eye
pharmaceutical composition
treating dry
Prior art date
Application number
SG1996011135A
Other languages
English (en)
Inventor
Noriko Watanabe
Takahiro Ogawa
Yasushi Okumura
Original Assignee
Senju Pharma Co
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Tanabe Seiyaku Co filed Critical Senju Pharma Co
Publication of SG42446A1 publication Critical patent/SG42446A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996011135A 1995-11-15 1996-11-14 Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom SG42446A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7322364A JP3059092B2 (ja) 1995-11-15 1995-11-15 ドライアイおよびドライアイを原因とする疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
SG42446A1 true SG42446A1 (en) 1997-08-15

Family

ID=18142826

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996011135A SG42446A1 (en) 1995-11-15 1996-11-14 Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom

Country Status (11)

Country Link
US (1) US5830913A (de)
EP (1) EP0774254B1 (de)
JP (1) JP3059092B2 (de)
KR (1) KR100425354B1 (de)
CN (1) CN1078464C (de)
AT (1) ATE179888T1 (de)
CA (1) CA2190303C (de)
DE (1) DE69602412T2 (de)
ES (1) ES2131373T3 (de)
SG (1) SG42446A1 (de)
TW (1) TW411275B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4982643B2 (ja) * 2000-09-14 2012-07-25 株式会社林原 眼科用医薬組成物
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
JP3945625B2 (ja) 2001-03-30 2007-07-18 株式会社イーエムアイ 角膜上皮障害モデル動物及びそのモデル動物を用いた薬剤の評価方法並びにその評価方法を用いて選択された薬剤
US6831101B2 (en) * 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
NZ531937A (en) * 2001-09-27 2005-09-30 Tanabe Seiyaku Co Aqueous ecabet sodium solution preparation
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
KR20070011497A (ko) * 2004-05-11 2007-01-24 산텐 세이야꾸 가부시키가이샤 각결막 장해 치료제
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
EP2389939A1 (de) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
US20130209531A1 (en) * 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
CA2812164A1 (en) * 2010-11-08 2012-05-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
JP2014501748A (ja) * 2010-12-21 2014-01-23 リコファーマ アーベー 涙代用物
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
EP3246037A4 (de) 2015-01-16 2018-07-11 Seikagaku Corporation Vernetztes chondroitinsulfat, zusammensetzung damit und behandlungsmittel für augenerkrankungen
CN106420797A (zh) * 2016-12-06 2017-02-22 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合及其制备方法
CN106581035A (zh) * 2016-12-06 2017-04-26 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合物
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
CN114588250B (zh) * 2022-03-18 2024-01-09 宁夏杞肽科技有限公司 枸杞糖肽在制备预防或治疗干眼症的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114975B (en) * 1981-10-22 1985-06-05 Tanabe Seiyaku Co Salts of sulfodehydroabietic acid and treatment of gastro-intestinal diseases
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion

Also Published As

Publication number Publication date
EP0774254B1 (de) 1999-05-12
CN1159323A (zh) 1997-09-17
TW411275B (en) 2000-11-11
DE69602412T2 (de) 1999-11-18
JP3059092B2 (ja) 2000-07-04
KR100425354B1 (ko) 2004-06-30
CN1078464C (zh) 2002-01-30
US5830913A (en) 1998-11-03
ATE179888T1 (de) 1999-05-15
KR970025612A (ko) 1997-06-24
EP0774254A1 (de) 1997-05-21
DE69602412D1 (de) 1999-06-17
ES2131373T3 (es) 1999-07-16
CA2190303C (en) 2007-01-16
CA2190303A1 (en) 1997-05-16
MX9605633A (es) 1998-05-31
JPH09136832A (ja) 1997-05-27

Similar Documents

Publication Publication Date Title
SG42446A1 (en) Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom
ES2132170T3 (es) Composicion de esteres de l-dopa.
AU3990797A (en) Sustained release formulation
ES2085886T3 (es) Composicion farmaceutica de liberacion contenida.
HU9600834D0 (en) Quinazoline derivatives
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
ATE121295T1 (de) Augentropfenarzneimittel.
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
EP0842923A4 (de) Pyrrolderivate und medizinische zubereitung.
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
EP0826373A4 (de) Prävention des nachoperativen astigmatismus
CA2237643A1 (en) Therapeutic agent for acute hepatic failure